Dr. Sunil A. Sheth, M.D.
Neurology (Vascular Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Harvard Medical School (2009)
- Years since graduation
- 17
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 128
Licensed in Texas since 2016, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Medical school: Harvard Medical School
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Neurology Physician primary
TX license Q9735 (first issued 2016; active) -
Neurology Physician
TX license Q9735 (first issued 2016; active) -
Neuroradiology Physician
TX license Q9735 (first issued 2016; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- Memorial Hermann - Texas Medical Center Houston, TX
- Memorial Hermann Memorial City Hospital Houston, TX
- Memorial Hermann Sugar Land Hospital Sugar Land, TX
Medical groups
- Ut Physicians (213 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 128
- Services billed
- 438
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 48 | 20 |
| Established patient office or other outpatient visit, 30-39 minutes | 24 | 21 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 22 | 18 |
| Established patient office or other outpatient visit, 20-29 minutes | 22 | 18 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 19 | 13 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 19 | 18 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 16 | 16 |
| New patient office or other outpatient visit, 45-59 minutes | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Houston, TX | 36 |
| Levetiracetam Other prescribers in Houston, TX | 19 |
| Atorvastatin Calcium Other prescribers in Houston, TX | 17 |
| Oxcarbazepine Other prescribers in Houston, TX | 11 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Houston, TX | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 10 payments worth $11,692 in total to this clinician.
| Route 92 Medical, Inc. | $6,530 |
|---|---|
| Perfuze Limited | $4,000 |
| Medtronic, Inc. | $700 |
| Vesalio, Inc. | $250 |
| Stryker Corporation | $164 |
| UCB, Inc. | $48.10 |
| Consulting Fee | $9,625 |
|---|---|
| Travel and Lodging | $1,124 |
| Compensation for services other than consulting (speaking, faculty) | $525 |
| Food and Beverage | $417 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Route 92 Medical, Inc. Jun 11, 2025 | Consulting Fee | $5,200 |
| Perfuze Limited Jul 18, 2025 | Consulting Fee | $4,000 |
| Route 92 Medical, Inc. Apr 28, 2025 | Travel and Lodging travel to NEW YORK, NY | $766 |
| Medtronic, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) | $525 |
| Route 92 Medical, Inc. May 8, 2025 | Travel and Lodging travel to NEW YORK, NY | $358 |
| Vesalio, Inc. Nov 13, 2025 | Consulting Fee | $250 |
| Medtronic, Inc. Jul 11, 2025 | Consulting Fee | $175 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $117,080 in research payments for these studies, mostly to the institutions running them.
- Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study
Balt USA, LLC · Recruiting · NCT06347796 - The imperative trial: treatment of acute ischemic stroke with the zoom reperfusion system
Imperative Care, Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.